The effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant model.
Islet transplantation has become a viable clinical treatment, but is still compromised by long-term graft failure. Exendin-4, a glucagon-like peptide 1 receptor agonist, has in clinical studies been shown to improve insulin secretion in islet transplanted patients. However, little is known about the...
Main Authors: | Afaf Sahraoui, Maria Sörhede Winzell, Tracy Gorman, Dave M Smith, Stanko Skrtic, Merete Hoeyem, Shadab Abadpour, Lars Johansson, Olle Korsgren, Aksel Foss, Hanne Scholz |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4368803?pdf=render |
Similar Items
-
Anakinra and Tocilizumab Enhance Survival and Function of Human Islets during Culture: Implications for Clinical Islet Transplantation
by: Afaf Sahraoui, et al.
Published: (2014-10-01) -
Glial cell-line derived neurotrophic factor protects human islets from nutrient deprivation and endoplasmic reticulum stress induced apoptosis
by: Shadab Abadpour, et al.
Published: (2017-05-01) -
Treatment with Tacrolimus and Sirolimus Reveals No Additional Adverse Effects on Human Islets In Vitro Compared to Each Drug Alone but They Are Reduced by Adding Glucocorticoids
by: Kristine Kloster-Jensen, et al.
Published: (2016-01-01) -
The mechanisms of the beneficial effect of the exendin-4 on islet grafts and the use of magnetic resonance imaging to detect and track grafted islets
by: 郭健葒
Published: (2012) -
Non-invasive in vivo determination of viable islet graft volume by 111In-exendin-3
by: Wael A. Eter, et al.
Published: (2017-08-01)